CH
WINT

CVI Holdings’s Windtree Therapeutics WINT Stock Holding History

CVI Holdings’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1
Closed -$226K – 119
2020
Q2 		$226K Buy
+1
New +$317K 0.08% 53

Other funds holding WINT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CVI Holdings's WINT Position: Q3 2020 in Review

CVI Holdings sold out of Windtree Therapeutics (WINT) in Q3 2020, closing a stake of 1 share — an estimated $226K sold.

CVI Holdings first reported a position in WINT in Q2 2020 and held it in 1 quarter. The position peaked at $226K in Q2 2020. 6 funds tracked by Wall St. Rank hold WINT as of Q3 2020.

  • CVI Holdings reported no remaining Windtree Therapeutics position as of Q3 2020 after selling out during the quarter.
  • CVI Holdings sold 1 Windtree Therapeutics share in Q3 2020, an estimated $226K.
  • CVI Holdings first reported a position in Windtree Therapeutics in Q2 2020 and held it in 1 quarter.
  • CVI Holdings's Windtree Therapeutics position peaked at $226K in Q2 2020.
  • 6 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.